Cipla Suspends Effort To Buy Majority Of South Africa's Cipla Medpro
This article was originally published in PharmAsia News
Executive Summary
Cipla has suspended its effort to buy a majority stake in the South Africa drug maker Cipla Medpro that shares its name, citing issues concerning its valuation.